New app aims to protect kids from radon, the second leading cause of lung cancer

NCT ID NCT07591389

Recruiting now Prevention Sponsor: University of North Dakota Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a smartphone app designed to encourage mothers of children aged 4 and under to test their homes for radon, a radioactive gas that is the second leading cause of lung cancer. Participants receive a free radon test kit and use the app to learn about radon risks. The study measures changes in radon knowledge, confidence, and whether participants actually use the test kit. It involves 100 mothers in North Dakota.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radon app
What this could lead to: If successful, this app could help reduce lung cancer risk by increasing radon testing in homes with young children.
What could go wrong: This is a small, early feasibility study with only 100 participants, so results may not apply broadly. The app's impact on actual radon testing and cancer prevention is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER (DIAGNOSIS)

Contacts and locations

Locations

University of North Dakota Center for Family Medicine, Bismarck Clinic
RECRUITING

Bismarck, North Dakota, 58501, United States
University of North Dakota Center for Family Medicine, Minot Clinic
RECRUITING

Minot, North Dakota, 58701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.